Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 38 Lung Neoplasms 29 Carcinoma, Non-Small-Cell Lung 28 Neoplasms 16 Uterine Cervical Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 11 Esophageal Neoplasms 10 Carcinoma, Hepatocellular 10 Sarcoma 9 Rectal Neoplasms 9 Carcinoma, Renal Cell 9 Prostatic Neoplasms 8 Neoplasm Metastasis 8 Melanoma 8 Lymphoma 8 Glioblastoma 8 Colorectal Neoplasms 8 Brain Neoplasms 8 Thyroid Neoplasms 7 Stomach Neoplasms 7 Solid Tumor 7 Pancreatic Neoplasms 7 Oropharyngeal Neoplasms 7 Multiple Myeloma 7 Head and Neck Neoplasms 7 Colonic Neoplasms 7 Urinary Bladder Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 6 Hodgkin Disease 6 Breast Neoplasms, Male 6

Interventions

Enoxaparin 4 Dalteparin 4 Tinzaparin 3 Saline Solution 3 Gemcitabine 3 Warfarin 2 Heparin, Low-Molecular-Weight 2 Heparin 2 Fondaparinux 2 Aspirin 2 130-nm albumin-bound paclitaxel 2 palbociclib 1 isoquercitrin 1 enoxaparin sodium 1 edoxaban 1 apixaban 1 alvocidib 1 Watchful Waiting 1 Tranexamic Acid 1 Sodium Chloride 1 Sodium Bicarbonate 1 Rivaroxaban 1 Pentetic Acid 1 PEGPH20 1 Nadroparin 1 Minocycline 1 Lenalidomide 1 Ketoconazole 1 Immunoenzyme Techniques 1 High-Energy Shock Waves 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thromboembolism × Fluorodeoxyglucose F18 × Clear all

NCT00964275 2014-12-08

MVTEP

University Hospital, Brest

Phase NA Completed

Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡